Pacific Biosciences of California

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$38,441
$39,766
$37,153
$39,224
Gross Profit
15,901
14,684
-1,371
10,058
EBITDA
-32,397
-35,575
-51,861
16,393
EBIT
-35,878
-40,157
-424,640
5,444
Net Income
-38,000
-41,930
-426,075
2,371
Net Change In Cash
38,441
39,766
37,153
39,224
Free Cash Flow
-18,621
-29,927
-50,445
-32,267
Cash
56,467
54,803
58,507
55,370
Basic Shares
300,844
300,162
296,858
306,892

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$154,014
$200,521
$128,304
$130,513
Gross Profit
37,282
52,780
49,035
58,860
EBITDA
-242,772
-271,125
-282,240
-250,757
EBIT
-296,123
-303,816
-299,558
-262,342
Net Income
-309,851
-306,735
-314,248
-181,223
Net Change In Cash
154,014
200,521
128,304
130,513
Cost of Revenue
379,870
Free Cash Flow
-212,246
-275,391
-280,140
-117,111
Cash
55,370
179,911
325,089
460,725
Basic Shares
288,366
253,629
224,550
204,136

Earnings Calls

QuarterEPS
2025-09-30
-$0.12
2025-06-30
-$0.13
2025-03-31
-$0.15
2024-12-31
-$0.20